| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Advanced glycation end productsReceptor (RAGE)Diabetes mellitus (Involvement of the eye)Hemodialysis (BASKET)| 1 | 2002 | Diabetes and advanced glycation endproducts. | 
| + | - | nl | J Intern Med 251(2):87-101 (2002) |
| 2 | 2008 | Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease. |
| + | - | nl | Cardiovasc Ther 26(1):50-8 (2008) Yamagishi S |
| 3 | 1998 | AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. |
| + | - | nl | Cardiovasc Res 37(3):586-600 (1998) |
| 4 | 2001 | Protein glycation, diabetes, and aging. | 
| + | - | nl | Recent Prog Horm Res 56(-):1-21 (2001) |
| 5 | 2010 | Advanced glycation end products, oxidative stress and diabetic nephropathy. |
| + | - | nl | Oxid Med Cell Longev 3(2):101-8 (2010) Yamagishi S |
| 6 | 2006 | Non-enzymatic glycation of proteins: a cause for complications in diabetes. |
| + | - | nl | Indian J Biochem Biophys 43(6):337-44 (2006) Nawale RB |
| 7 | 2005 | Advanced glycation end products and the kidney. |
| + | - | nl | Am J Physiol Renal Physiol 289(4):F645-59 (2005) Bohlender JM |
| 8 | 2001 | Advanced glycation end products, their receptors and diabetic angiopathy. |
| + | - | nl | Diabetes Metab 27(5 Pt 1):535-42 (2001) |
| 9 | 2003 | Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. |
| + | - | nl | J Am Soc Nephrol 14(5):1383-95 (2003) Wendt T |
| 10 | 2000 | Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. |
| + | - | nl | J Am Soc Nephrol 11(9):1744-52 (2000) |
| 11 | 1996 | Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. |
| + | - | nl | J Am Soc Nephrol 7(2):183-90 (1996) Cohen MP |
| 12 | 2008 | Clinical review: The role of advanced glycation end products in progression and complications of diabetes. |
| + | - | nl | J Clin Endocrinol Metab 93(4):1143-52 (2008) Goh SY |
| 13 | 2005 | Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. |
| + | - | nl | J Pharmacol Sci 97(3):305-11 (2005) |
| 14 | 2005 | Advanced glycation and retinal pathology during diabetes. |
| + | - | nl | Pharmacol Rep 57 Suppl(-):156-68 (2005) |
| 15 | 2010 | Tissue-advanced glycation end product concentration in dialysis patients. | 
| + | - | nl | Clin J Am Soc Nephrol 5(1):51-5 (2010) |
